179 related articles for article (PubMed ID: 14669163)
1. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.
Tsukahara H; Shibata R; Ohta N; Sato S; Hiraoka M; Ito S; Noiri E; Mayumi M
Metabolism; 2003 Dec; 52(12):1601-5. PubMed ID: 14669163
[TBL] [Abstract][Full Text] [Related]
2. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.
Tsukahara H; Sekine K; Uchiyama M; Kawakami H; Hata I; Todoroki Y; Hiraoka M; Kaji M; Yorifuji T; Momoi T; Yoshihara K; Beppu M; Mayumi M
Pediatr Res; 2003 Sep; 54(3):419-24. PubMed ID: 12761359
[TBL] [Abstract][Full Text] [Related]
3. The relationship of oxidative DNA damage marker 8-hydroxydeoxyguanosine and glycoxidative damage marker pentosidine.
Kouda K; Nakamura H; Fan W; Horiuchi K; Takeuchi H
Clin Biochem; 2001 May; 34(3):247-50. PubMed ID: 11408024
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis.
Tsukahara H; Shibata R; Ohshima Y; Todoroki Y; Sato S; Ohta N; Hiraoka M; Yoshida A; Nishima S; Mayumi M
Life Sci; 2003 Apr; 72(22):2509-16. PubMed ID: 12650859
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes.
Daimon M; Sugiyama K; Kameda W; Saitoh T; Oizumi T; Hirata A; Yamaguchi H; Ohnuma H; Igarashi M; Kato T
Endocr J; 2003 Feb; 50(1):61-7. PubMed ID: 12733710
[TBL] [Abstract][Full Text] [Related]
6. Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.
Kageyama Y; Takahashi M; Nagafusa T; Torikai E; Nagano A
Rheumatol Int; 2008 Jan; 28(3):245-51. PubMed ID: 17661050
[TBL] [Abstract][Full Text] [Related]
7. Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy.
Aso Y; Takanashi K; Sekine K; Yoshida N; Takebayashi K; Yoshihara K; Inukai T
J Lab Clin Med; 2004 Aug; 144(2):92-9. PubMed ID: 15322503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults.
Tamura S; Tsukahara H; Ueno M; Maeda M; Kawakami H; Sekine K; Mayumi M
Free Radic Res; 2006 Nov; 40(11):1198-205. PubMed ID: 17050173
[TBL] [Abstract][Full Text] [Related]
9. Increased pentosidine, an advanced glycation end-product, in urine and tissue reflects disease activity in inflammatory bowel diseases.
Kato S; Itoh K; Ochiai M; Iwai A; Park Y; Hata S; Takeuchi K; Ito M; Imaki J; Miura S; Yakabi K; Kobayashi M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S140-5. PubMed ID: 19120887
[TBL] [Abstract][Full Text] [Related]
10. Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.
Kageyama Y; Takahashi M; Ichikawa T; Torikai E; Nagano A
Clin Exp Rheumatol; 2008; 26(1):73-80. PubMed ID: 18328150
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis.
Kageyama Y; Takahashi M; Nagafusa T; Torikai E; Nagano A
Mod Rheumatol; 2007; 17(5):398-402. PubMed ID: 17929132
[TBL] [Abstract][Full Text] [Related]
12. Development and Evaluation of Novel ELISA for Determination of Urinary Pentosidine.
Kashiwabara S; Hosoe H; Ohno RI; Nagai R; Shiraki M
J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):526-533. PubMed ID: 31902866
[TBL] [Abstract][Full Text] [Related]
13. Determination of urinary pyrraline by solid-phase extraction and high performance liquid chromatography.
Yoshihara K; Kiyonami R; Shimizu Y; Beppu M
Biol Pharm Bull; 2001 Aug; 24(8):863-6. PubMed ID: 11510474
[TBL] [Abstract][Full Text] [Related]
14. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
Li H; Yu SJ
J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.
Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N
Mol Autism; 2018; 9():3. PubMed ID: 29479405
[TBL] [Abstract][Full Text] [Related]
16. Associations between Levels of Urinary Oxidative Stress of 8-OHdG and Risk of Atopic Diseases in Children.
Chen PY; Chen CW; Su YJ; Chang WH; Kao WF; Yang CC; Wang IJ
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33172083
[TBL] [Abstract][Full Text] [Related]
17. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis.
Nakai K; Yoneda K; Maeda R; Munehiro A; Fujita N; Yokoi I; Moriue J; Moriue T; Kosaka H; Kubota Y
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1405-8. PubMed ID: 20205355
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis.
Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
Br J Rheumatol; 1997 Jun; 36(6):637-42. PubMed ID: 9236672
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
